ArticleJournal of experimental & clinical cancer research : CR2018

Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy.

Man Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.